Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 23, 2015
IDT Biologika has announced the dedication of its first U.S. vaccine manufacturing facility in Rockville, Maryland.
read more
A major manufacturer of human vaccines designed to address some of the world’s most dangerous infectious diseases, IDT Biologika today announced it has completed and certified the construction of a large-scale production facility dedicated to filling...
read more
IDT Biologika and Exothera announced a collaboration to develop a large-scale manufacturing process for viral vector-based vaccines. The feasibility study is focussing on Modified Vaccinia Ankara (MVA) virus as a first example for IDT’s broad range ...
read more
IDT Biologika announced the NIAID of the NIH has awarded the company a new Task Order within the 10-year contract to provide manufacturing of five E. coli Master Cell Banks.
read more
Friday, November 08, 2019
IDT Biologika announced the NIAID of the NIH has awarded the company a new Task Order within the 10-year IDIQ to provide process development activities and production of a vaccine against the RSV.
read more
IDT Biologika announced the NIAID has awarded the company a 10-year Indefinite Quantity, Indefinite Delivery to provide process development, manufacturing and characterization of vaccine and biologic products for infectious diseases.
read more
Wednesday, August 26, 2015
IDT Biologika announces today the acquisition of Gallant Custom Laboratories, based in Ontario, Canada. The transaction is to close August 31, 2015.
read more
IDLogiq® innovations have been selected by the FDA for the Pilot Project Program under the DSCSA to prototype and develop a system that can address the national security of the drug supply chain.
read more
Tuesday, November 08, 2016
Spanish contract development and manufacturing organization (CDMO) Idifarma has grown by more than 50%in the last two years as it continues to expand its international customer base and strengthen its specialist production capabilities.
read more
Wednesday, December 07, 2016
Idifarma has acquired a Bosch GKF-702 capsule filling machine, capable of manufacturing from 3,000 to 42,000 capsules per hour. The new equipment will be installed at the CDMO’s EU-GMP approved plant in Pamplona, Spain, in early 2017.
read more
Idifarma has begun its seventh project with Spanish biotechnology company, Palobiofarma.
read more
A CDMO has expanded its GMP manufacturing offering with the installation of new automatic capsule filling capabilities at its EU-GMP approved plant in Spain.
read more
Thursday, December 03, 2020
Idifarma has announced a partnership with Stefano Console from Swiss life sciences consultancy Oriento.
read more
Wednesday, March 28, 2018
Idifarma has announced new GMP spray drying capabilities for highly potent drugs up to Category 4 OEL/OEB.
read more
Wednesday, March 18, 2020
IDEAYA has entered into a clinical trial collaboration and supply agreement with Pfizer for an IDEAYA-sponsored clinical combination study of IDE196 in the U.S. and Canada.
read more